- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Efficacy and safety of surgery in renal carcinoma patients 75 years and older: a retrospective analysis.
September 1, 2022
The controversial role and therapeutic development of the m6A demethylase FTO in renal cell carcinoma.
August 31, 2022
Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature.
August 31, 2022
A prognosis model for clear cell renal cell carcinoma based on four necroptosis-related genes.
August 30, 2022
Assessing Trifecta Achievement after Percutaneous Cryoablation of Small Renal Masses: Results from a Multi-Institutional Collaboration.
August 30, 2022
Adding Cyclooxygenase Inhibitors to Immune Checkpoint Inhibitors Did Not Improve Outcomes in Metastatic Renal Cell Carcinoma.
August 30, 2022
The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature.
August 30, 2022
Analysis of Trifecta Results in a Single-Center Experience with Retroperitoneoscopic Partial Nephrectomy: An Observational Study.
August 26, 2022
Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer.
August 26, 2022
Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma.
August 25, 2022
BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma.
August 24, 2022
C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab.
August 23, 2022
Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma.
August 23, 2022